MicroPort CardioFlow Medtech Corporation (HKG:2160)

HKG:2160 Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	69.57	15.03	150.2	270.59	348.13
Short-Term Investments	119.75	174.17	100.21	30.84	32.49
Cash & Short-Term Investments	189.32	189.2	250.42	301.43	380.63
Cash Growth	0.06%	-24.45%	-16.92%	-20.81%	299.69%
Accounts Receivable	74.16	21.67	14.24	7.22	11.76
Other Receivables	13.02	2.12	4.45	0.67	3.79
Receivables	88.67	23.79	18.69	7.89	15.55
Inventory	87.17	18.83	17.33	16.55	13.02
Other Current Assets	8.04	1.12	1.44	3.5	0.05
Total Current Assets	373.2	232.94	287.88	329.38	409.25
Property, Plant & Equipment	102.1	70.39	27.78	35.05	42.06
Long-Term Investments	31.73	34.53	23.6	43.23	36.36
Goodwill	109.37	-	-	-	-
Other Intangible Assets	9.62	0.27	0.48	0.32	0.08
Long-Term Deferred Tax Assets	10.1	-	-	-	-
Long-Term Deferred Charges	23.06	26.48	19.81	23.33	37.5
Other Long-Term Assets	10.49	6.21	3.88	3.84	3.98
Total Assets	669.67	372.23	363.44	435.14	529.23

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	37.37	5.54	7.51	6.91	8.65
Accrued Expenses	31.67	4.02	5.31	4.12	3.17
Current Portion of Long-Term Debt	18.77	5.22	-	-	-
Current Portion of Leases	4.68	3.56	4.03	4.5	5.46
Current Income Taxes Payable	3.03	0.97	1.02	0.26	-
Current Unearned Revenue	8.58	0.74	0.7	0.88	0.47
Other Current Liabilities	43.68	40.32	8.74	9.02	8.14
Total Current Liabilities	147.78	60.36	27.3	25.7	25.88
Long-Term Debt	187.58	0.56	-	-	-
Long-Term Leases	21.22	1.36	5.91	9.34	14.31
Long-Term Unearned Revenue	31.93	0.89	0.95	0.85	0.35
Pension & Post-Retirement Benefits	7.79	-	-	-	-
Other Long-Term Liabilities	17.15	-	-	-	1.24
Total Liabilities	413.44	63.17	34.16	35.89	41.8

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.03	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,189	640.17	588.27	603.75	653.42
Retained Earnings	-280.25	-262.19	-246.56	-185.41	-129.82
Comprehensive Income & Other	-652.57	-73.72	-12.44	-19.1	-36.19
Total Common Equity	256.23	304.27	329.28	399.25	487.43
Minority Interest	-	4.8	-	-	-
Shareholders' Equity	256.23	309.07	329.28	399.25	487.43
Total Liabilities & Equity	669.67	372.23	363.44	435.14	529.23

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	232.24	10.69	9.94	13.84	19.78
Net Cash (Debt)	-42.92	178.51	240.48	287.59	360.85
Net Cash Growth	-	-25.77%	-16.38%	-20.30%	288.82%
Net Cash Per Share	-0.09	0.38	0.51	0.61	0.77
Filing Date Shares Outstanding	1,273	482.52	482.5	481.88	480.71
Total Common Shares Outstanding	1,273	482.52	482.5	481.88	480.71
Working Capital	225.42	172.58	260.58	303.68	383.37
Book Value Per Share	0.20	0.63	0.68	0.83	1.01
Tangible Book Value	137.24	304.01	328.79	398.93	487.35
Tangible Book Value Per Share	0.11	0.63	0.68	0.83	1.01
Buildings	26.29	25.71	-	-	-
Machinery	74.33	14.92	13.59	12.44	8.68
Construction In Progress	2.39	0.07	0.48	0.89	11.58
Leasehold Improvements	21.22	12.23	11.23	12.55	3.76

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error